29.79
-0.36 (-1.18%)
AIStockmoo Score
| Value 38% | 0.0 |
| AI Insight info | NA |
| Relative Valuation info | NA |
| Financial Health info | 0.0 |
| Timing 38% | 1.2 |
| AI Technical info | NA |
| Technical Oscillators info | 2.0 |
| Technical Moving Averages info | 0.0 |
| Candle Patterns info | NA |
| Sentiment 25% | 0.0 |
| Analyst Consensus info | 0.0 |
| News Mood info | NA |
| Smart Money | NA |
| Insider Activity info | NA |
| Institutional Flow info | NA |
| Short Interest info | NA |
| Environment | ×0.87 |
| Macro Environment info | -1.3 |
| Sector vs Market (6M) | -28.2% |
| Pillar Agreement | ×1.00 |
| Not in score | |
| Price Volatility info | 5.0 |
| Final Score | 0.39 |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Vera Therapeutics, Inc. | Mixed | Bullish |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| VERA | - | - | - | 5.65 |
| SLNO | 3 B | - | 135.77 | - |
| VIR | - | - | - | 2.29 |
| HUMA | - | - | - | 8.59 |
| PHAR | - | - | - | 3.18 |
| ARQT | - | - | - | 14.60 |
Select this tab to load the latest available analysis.
|
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Growth |
| % Held by Insiders | 3.97% |
| % Held by Institutions | 112.39% |
No data within this time range.
No data within this time range.
Recent Signals candle patterns and EMA crosses
AI Technical Analysis
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |